Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: Natural history based on liver biopsy analysis

Liver Transplantation

Volumn 20, Issue 9, 2014, Pages 1064-1071

  Vallin, Mélanie ^a   Guillaud, Olivier ^a   Boillot, Olivier ^a   Hervieu, Valérie ^b   Scoazec, Jean Yves ^b   Dumortier, Jérôme ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DE NOVO NONALCOHOLIC FATTY LIVER; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT NONALCOHOLIC FATTY LIVER; SEX RATIO; STEATOSIS; ADVERSE EFFECTS; BIOPSY; COMORBIDITY; FRANCE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; BIOPSY; COMORBIDITY; FEMALE; FRANCE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906704904     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23936     Document Type: Article

References (25)

1. Neuschwander-Tetri BA, Caldwell SH,. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-1219.
2. Farrell GC, Larter CZ,. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (suppl 1): S99-S112.
3. Cattral MS, Lilly LB, Levy GA,. Immunosuppression in liver transplantation. Semin Liver Dis 2000; 20: 523-531.
4. Patil DT, Yerian LM,. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. Liver Transpl 2012; 18: 1147-1153.
5. Burke A, Lucey MR,. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686-693.
6. Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol 2010; 105: 613-620.
7. McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL,. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 2006; 6: 1578-1585.
8. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al.; for Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
9. Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007; 13: 844-847.
10. Dureja P, Mellinger J, Agni R, Chang F, Avey G, Lucey M, Said A,. NAFLD recurrence in liver transplant recipients. Transplantation 2011; 91: 684-689.
11. Kim WR, Poterucha JJ, Porayko MK, Dickson ER, Steers JL, Wiesner RH,. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996; 62: 1802-1805.
12. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7: 363-373.
13. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001; 7: 608-614.
14. Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, Boparai N,. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001; 7: 797-801.
15. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U,. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 2002; 33: 1098-1104.
16. Sanjeevi A, Lyden E, Sunderman B, Weseman R, Ashwathnarayan R, Mukherjee S,. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 2003; 35: 2977-2980.
17. Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J,. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl 2009; 15: 1843-1851.
18. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A,. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009; 15: 1814-1820.
19. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL,. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010; 16: 431-439.
20. El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant 2012; 26: E505-E512.
21. Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V,; for LIDO Study Group. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013; 59: 550-556.
22. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
23. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH,. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-379.
24. Di Rosa M, Malaguarnera L,. Genetic variants in candidate genes influencing NAFLD progression. J Mol Med (Berl) 2012; 90: 105-118.
25. Sprinzl MF, Weinmann A, Lohse N, Tönissen H, Koch S, Schattenberg J, Hoppe-Lotichius M, Zimmermann T, Galle PR, Hansen T, Otto G, Schuchmann M., Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. Transpl Int. 2013; 26: 67-74.